News Digging > Editor's Picks > WSJ News Exclusive | Pfizer in Talks to Acquire Seagen in Deal Likely Valued at More Than $30 Billion
WSJ News Exclusive | Pfizer in Talks to Acquire Seagen in Deal Likely Valued at More Than  Billion
WSJ News Exclusive | Pfizer in Talks to Acquire Seagen in Deal Likely Valued at More Than $30 Billion,The potential deal, likely valued at more than $30 billion, would help Pfizer add to its lineup of cancer treatments.

WSJ News Exclusive | Pfizer in Talks to Acquire Seagen in Deal Likely Valued at More Than $30 Billion

The potential deal, likely valued at more than $30 billion, would help Pfizer add to its lineup of cancer treatments.